Intrathecal Drug Delivery for Pain and Spasticity: Volume 2: A Volume in the Interventional and Neuromodulatory Techniques for Pain Management Series: Interventional and Neuromodulatory Techniques in Pain Management
Autor Asokumar Buvanendran, Sudhir Diwan, Timothy R. Deeren Limba Engleză Hardback – 10 oct 2011
Preț: 598.85 lei
Preț vechi: 762.39 lei
-21% Nou
Puncte Express: 898
Preț estimativ în valută:
114.60€ • 119.50$ • 95.25£
114.60€ • 119.50$ • 95.25£
Carte disponibilă
Livrare economică 28 februarie-12 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781437722178
ISBN-10: 1437722172
Pagini: 224
Ilustrații: 46 illustrations (46 in full color)
Dimensiuni: 216 x 276 x 15 mm
Greutate: 0.79 kg
Editura: Elsevier
Seria Interventional and Neuromodulatory Techniques in Pain Management
ISBN-10: 1437722172
Pagini: 224
Ilustrații: 46 illustrations (46 in full color)
Dimensiuni: 216 x 276 x 15 mm
Greutate: 0.79 kg
Editura: Elsevier
Seria Interventional and Neuromodulatory Techniques in Pain Management
Cuprins
SECTION I: General Considerations
Chapter 1: Basic Science of Spinal Receptors
Chapter 2: Pharmacologic Agents and Compounding of Intrathecal Drugs
Chapter 3: Polyanalgesia for Implantable Drug Delivery Systems
Chapter 4: Principles of Patient Management for Intrathecal Analgesia
Chapter 5: Patient Selection for Intrathecal Infusion to Treat Chronic Pain
Chapter 6: Patient Preparation
Chapter 7: Psychological Considerations in IDD
Chapter 8: Intrathecal Drug Delivery: Medical Necessity, Documentation, Coding and Billing
SECTION II: Implant Devices
Chapter 9: Methods of Trials for Consideration of ITDDS
Chapter 10: Techniques of Implant Placement for Intrathecal Pumps
Chapter 11: Programmable versus Fixed-Rate Pumps for Intrathecal Drug Delivery
Chapter 12: SynchroMed EL vs SynchroMed II
Chapter 13: Minimizing the Risks of Intrathecal Therapy
Chapter 14: Complications Associated with Intrathecal Drug Delivery Systems
SECTION III: Evidence-based practice
Chapter 15: Management of ITDDS in Patients with Co-Morbidities
Chapter 16: Cost-Effectiveness of Implanted Drug Delivery Systems
Chapter 17: Neuroaugmentation by Stimulation vs. Intrathecal Drug Delivery Systems
Chapter 18: Anticoagulation guidelines and Intrathecal Drug Delivery Systems
Chapter 19: Intrathecal Therapy for Malignant Pain
SECTION IV: ITDDs for spasticity
Chapter 20: Intrathecal Baclofen Trialing
Chapter 21: Baclofen Pump Management
SECTION V: Future of ITDDs
Chapter 22: Future of Intrathecal Drug Delivery Systems (including new devices)
Chapter 23: Trialing for Ziconotide Intrathecal Analgesic Therapy
Chapter 24: Perioperative Management of Patients with ITDDS
Chapter 1: Basic Science of Spinal Receptors
Chapter 2: Pharmacologic Agents and Compounding of Intrathecal Drugs
Chapter 3: Polyanalgesia for Implantable Drug Delivery Systems
Chapter 4: Principles of Patient Management for Intrathecal Analgesia
Chapter 5: Patient Selection for Intrathecal Infusion to Treat Chronic Pain
Chapter 6: Patient Preparation
Chapter 7: Psychological Considerations in IDD
Chapter 8: Intrathecal Drug Delivery: Medical Necessity, Documentation, Coding and Billing
SECTION II: Implant Devices
Chapter 9: Methods of Trials for Consideration of ITDDS
Chapter 10: Techniques of Implant Placement for Intrathecal Pumps
Chapter 11: Programmable versus Fixed-Rate Pumps for Intrathecal Drug Delivery
Chapter 12: SynchroMed EL vs SynchroMed II
Chapter 13: Minimizing the Risks of Intrathecal Therapy
Chapter 14: Complications Associated with Intrathecal Drug Delivery Systems
SECTION III: Evidence-based practice
Chapter 15: Management of ITDDS in Patients with Co-Morbidities
Chapter 16: Cost-Effectiveness of Implanted Drug Delivery Systems
Chapter 17: Neuroaugmentation by Stimulation vs. Intrathecal Drug Delivery Systems
Chapter 18: Anticoagulation guidelines and Intrathecal Drug Delivery Systems
Chapter 19: Intrathecal Therapy for Malignant Pain
SECTION IV: ITDDs for spasticity
Chapter 20: Intrathecal Baclofen Trialing
Chapter 21: Baclofen Pump Management
SECTION V: Future of ITDDs
Chapter 22: Future of Intrathecal Drug Delivery Systems (including new devices)
Chapter 23: Trialing for Ziconotide Intrathecal Analgesic Therapy
Chapter 24: Perioperative Management of Patients with ITDDS